ReviewJournal of molecular medicine (Berlin, Germany)2013

Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.

Michail Sitkovsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.